FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Recruiting · NCT06564389 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 1 | 2026-07-22 | NCT06564389 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | United States | 5 |
| Miami Dermatology and Laser Research | Miami | United States | 3 |
| Paddington Testing Company | Philadelphia | United States | 3 |
| Revival Research Institute, LLC | Troy | United States | 18 |
| TCR Medical Corporation | San Diego | United States | 1 |